MeiraGTx Holdings plc

10/01/2022 | Press release | Distributed by Public on 10/01/2022 08:05

Late-Breaking Phase 1/2 Data Demonstrates Safety Profile of Investigational Gene Therapy Botaretigene Sparoparvovec (AAV-RPGR) and Sustained Vision Improvement in Patients with[...]